Expression of the corticotropin-releasing hormone-proopiomelanocortin axis in the various clinical types of psoriasis

被引:49
作者
Kim, Jung Eun
Cho, Dae Ho
Kim, Hei Sung
Kim, Hee Jung
Lee, Jun Young
Cho, Baik Kee
Park, Hyun Jeong
机构
[1] Catholic Univ Korea, St Marys Hosp, Coll Med, Dept Dermatol, Seoul 150713, South Korea
[2] Sookmyung Womens Univ, Dept Life Sci, Seoul, South Korea
关键词
CRH-POMC axis; psoriasis; stress;
D O I
10.1111/j.1600-0625.2006.00509.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Psychological stress is known to aggravate inflammatory skin diseases such as atopic dermatitis, psoriasis and contact sensitivity by altering the cellular constituents of the immune system. The skin appendages function dually as prominent targets and sources of the peripheral corticotropin-releasing hormone-proopiomelanocortin (CRH-POMC) axis. In this study, we examined the expression level of CRH-POMC axis constituents in psoriasis, a well-known stress-related inflammatory skin disease. The 15 psoriasis patients and six normal controls were retrospectively selected after extensive review of their clinical records and skin biopsy specimens. We immunohistochemically analysed the expressivity of CRH, adrenocorticotrophic hormone (ACTH) and alpha-melanocyte-stimulating hormone (alpha-MSH) in various types of psoriatic lesions and control skin. A significant increase of CRH expression was observed in psoriatic lesions, which involved the entire epidermis (upper layer in particular), hair follicles and sweat glands compared with controls. Expression of ACTH and alpha-MSH was clearly stimulated in a subset of psoriasis patients compared with controls, but on the whole, lacked statistical significance. The immunoreactivity of CRH, ACTH and alpha-MSH in psoriasis was not dependent on its clinical subtype, duration or number of previous treatments. Compared with the definite increase of CRH expression in psoriasis, the expression of the POMC peptides was heterogenous with no overall significance. From the findings, we suggest that CRH, a key stress hormone, may play an important role in the pathomechanism of psoriasis.
引用
收藏
页码:104 / 109
页数:6
相关论文
共 30 条
  • [1] Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor
    Cao, J
    Papadopoulou, N
    Kempuraj, D
    Boucher, WS
    Sugimoto, K
    Cetrulo, CL
    Theoharides, TC
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 174 (12) : 7665 - 7675
  • [2] Endocrinology of the stress response
    Charmandari, E
    Tsigos, C
    Chrousos, G
    [J]. ANNUAL REVIEW OF PHYSIOLOGY, 2005, 67 : 259 - 284
  • [3] Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal (HPA) axis and synthesize cortisol
    Ito, N
    Ito, T
    Kromminga, A
    Bettermann, A
    Takigawa, M
    Kees, F
    Straub, RH
    Paus, R
    [J]. FASEB JOURNAL, 2005, 19 (08) : 1332 - +
  • [4] Corticotropin-releasing factor receptor type 1 is involved in the stress-induced exacerbation of chronic contact dermatitis in rats
    Kaneko, K
    Kawana, S
    Arai, K
    Shibasaki, T
    [J]. EXPERIMENTAL DERMATOLOGY, 2003, 12 (01) : 47 - 52
  • [5] Immunoreactivity of corticotropin-releasing hormone, adrenocorticotropic hormone and α-melanocyte-stimulating hormone in alopecia areata
    Kim, Hei Sung
    Cho, Dae Ho
    Kim, Hee Jung
    Lee, Jun Young
    Cho, Baik Kee
    Park, Hyun Jeong
    [J]. EXPERIMENTAL DERMATOLOGY, 2006, 15 (07) : 515 - 522
  • [6] In situ expression of corticotropin-releasing hormone (CRH) and proopiomelanocortin (POMC) genes in human skin
    Kono, M
    Nagata, H
    Umemura, S
    Kawana, S
    Osamura, RY
    [J]. FASEB JOURNAL, 2001, 15 (10) : 2297 - +
  • [7] O'Kane M, 2006, EXP DERMATOL, V15, P143
  • [8] Neuroimmunoendocrine circuitry of the 'brain-skin connection'
    Paus, R
    Theoharides, TC
    Arck, PC
    [J]. TRENDS IN IMMUNOLOGY, 2006, 27 (01) : 32 - 39
  • [9] Corticotropin releasing factor receptors and their ligand family
    Perrin, MH
    Vale, WW
    [J]. CUTANEOUS NEUROIMMUNOMODULATION: THE PROOPIOMELANOCORTIN SYSTEM, 1999, 885 : 312 - 328
  • [10] QUEVEDO ME, IN VITRO CELL DEV BI, V37, P50